Medications

How is the pharmaceutical industry responding to COVID-19?

As pharmaceutical companies work to develop potential vaccines and treatments for COVID-19, they are operating under extreme pressure—as well as the restrictions on movement and interaction that are affecting all of us. ...

Medications

Nigeria's reliance on drug imports in the time of COVID-19

The spread of COVID-19 has been slow in Nigeria compared to other countries on the continent. Nevertheless, the federal government has taken steps in readiness for a more rapid outbreak. Schools have been closed, public ...

Medications

Improving competition and reducing costs of bio-pharmaceuticals

Georgia State Law associate professor Yaniv Heled focuses his career on the intersection of biotechnology and the law. For nearly a decade, he has dedicated much of his research to the regulation of bio-pharmaceuticals (also ...

Medications

Antimalarial drug no better than standard coronavirus care: study

Hydroxychloroquine, an antimalarial drug dubbed a "gift from God" by US President Donald Trump for its potential ability to fight the new coronavirus, was found to be no more effective than standard treatment in a small Chinese ...

Diseases, Conditions, Syndromes

Why the coronavirus and most other viruses have no cure

People hospitalized with severe symptoms from the coronavirus are given medicine to bring down the fever and fluids to keep them hydrated, generally by intravenous tube. Some patients are connected to a ventilator: a mechanical ...

Medical research

S1P and its receptor: New approaches to cancer?

In 1998, when Timothy Hla, Ph.D., and his colleagues identified and cloned the receptor for sphingosine-1-phosphate (S1P), it generated a lot of excitement. S1P, a lipid originally discovered in the 1960s, was known to play ...

Medications

Is it time to nationalize the drug industry?

Critics of the pharmaceutical industry say it is misaligned with public interest. So is it time to nationalise the sector? Experts debate the issue in The BMJ today.

Pediatrics

Coronavirus treatment and risk to breastfeeding women

Little data is available about the ability of antiviral drugs used to treat COVID-19, coronavirus, to enter breastmilk, let alone the potential adverse effects on breastfeeding infants. A new perspective article reviewing ...

Medications

US reports first drug shortage tied to virus outbreak

Health officials reported the first U.S. drug shortage tied to the viral outbreak that is disrupting production in China, but they declined to identify the manufacturer or the product.

page 24 from 40